Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported higher neutralizing antibody levels in people who were given its COVID-19 vaccine as a booster after two AstraZeneca doses, the company said.
In a trial of 200 participants who received Medigen’s COVID-19 vaccine, neutralizing antibodies against the Omicron variant of SARS-CoV-2 grew by 5.7 times one month after being administered, Taoyuan General Hospital said.
Medigen said that the results have been submitted to medRxiv, an online platform for researchers to share complete but unpublished papers.
Photo: Chu Pei-hsiung, Taipei Times
Another trial conducted by National Taiwan University Hospital showed that among 45 participants who received three doses of the Medigen vaccine, the level of neutralizing antibodies against the Omicron variant gradually fell, similar to those who received three doses of mRNA COVID-19 vaccines such as those made by Pfizer-BionNTech and Moderna Inc.
“This result indicates that our vaccine, as a booster shot, provided protection against the Omicron variant to some degree,” Medigen said.
The company said that people who have received adenovirus-based vaccines, such as the one made by AstraZeneca, or mRNA-based vaccines could consider taking the Medigen vaccine as a third shot given its safety profile, mild side effects and immunogenicity.
Medigen’s vaccine is a protein subunit vaccine, developed by recombinant technology. It comprises the recombinant spike protein of SARS-CoV-2 as the antigen to help a person’s body recognize the virus if a person becomes infected.
The company said that it would recruit 960 participants for a “mix-and-match” clinical trial in which it plans to test the safety and immunogenicity of different combinations of multiple brands of COVID-19 vaccines.
Medigen has received a subsidy of US$2.3 million from the Coalition for Epidemic Preparedness Innovations, an international foundation, to conduct the trial.
The trial is to be carried out in four hospitals, and recruitment of participants has begun, it said.
As of Sunday, 1.51 million people had received two doses of Medigen’s vaccine, accounting for four percent of 36.17 million who had received two COVID-19 shots, while 112,838 people had chosen the vaccine as booster shot, Centers for Disease Control data showed.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day